[1]
Lubis, A. and Siregar, G.A. 2022. The Differences of Pepsinogen I and H. Pylori Levels in Patients With Gastric Premalignant Lesion. Journal of Endocrinology, Tropical Medicine, and Infectious Disease (JETROMI). 4, 1 (Jun. 2022), 42–49. DOI:https://doi.org/10.32734/jetromi.v4i1.8792.